Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patients With Functional Dyspepsia

Conditions: Functional Dyspepsia Interventions: Drug: Itopride Hydrochloride 150 mg extended release tablets; Drug: Itopride Hydrochloride 50 mg film coated tablets Sponsors: Abbott Not yet recruiting

https://clinicaltrials.gov/study/NCT06217393

Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials

More News: Dyspepsia | Research